lansoprazole · Dexcel · NDA 208025
Lansoprazole
Earliest generic entry, as listed
21 Apr 2036
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 11077055, US 11986554.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11077055 | drug product · sets the listed date | 21 Apr 2036 |
| US 11986554 | drug product · sets the listed date | 21 Apr 2036 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208025 · 001 | tablet, orally disintegrating, delayed release, oral | 15MG | 21 Apr 2036 |